AbbVie CMO Services

AbbVie, the speciality biopharmaceutical company has once again made headway in the treatment of Parkinson’s disease. 

Following a successful few days in Philadelphia for CPHI North America, I was able to discuss some of the sessions with our expert speakers, gaining a little more insight into the key topics from the event. 

The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). 

Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are already 26 novel drug approvals (at time of writing), for half way through the year this is already a staggering number, showing just how successful the investments into innovations are in the industry. 

AbbVie and Genmab recently received approval from the US FDA for their joint venture, the blood cancer therapy epcoritamab, sold under the brand name EPKINLY.